oxacillin has been researched along with sparfloxacin in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (50.00) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Cui, L; Hiramatsu, K; Neoh, HM; Shoji, M | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chaudhry, AZ; Knapp, CC; Sierra-Madero, J; Washington, JA | 1 |
Cimbro, M; Dos Santos, C; Ferrara, A; Gialdroni Grassi, G | 1 |
Ballow, CH; Deinhart, JA; Johnson, DM; Jones, RN; Schentag, JJ | 1 |
6 other study(ies) available for oxacillin and sparfloxacin
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Contribution of vraSR and graSR point mutations to vancomycin resistance in vancomycin-intermediate Staphylococcus aureus.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; Chromosome Walking; DNA-Binding Proteins; Genetic Engineering; Genome, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Point Mutation; Sequence Analysis, DNA; Sequence Homology, Amino Acid; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Antistaphylococcal activities of sparfloxacin (CI-978; AT-4140), ofloxacin, and ciprofloxacin.
Topics: Anti-Infective Agents; Cell Adhesion; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Ofloxacin; Oxacillin; Plastics; Staphylococcus aureus; Staphylococcus epidermidis | 1990 |
Effect of different combinations of sparfloxacin, oxacillin, and fosfomycin against methicillin-resistant staphylococci.
Topics: Anti-Infective Agents; Drug Synergism; Drug Therapy, Combination; Fluoroquinolones; Fosfomycin; Methicillin Resistance; Microbial Sensitivity Tests; Oxacillin; Quinolones; Staphylococcus | 1997 |
Comparative in vitro assessment of sparfloxacin activity and spectrum using results from over 14,000 pathogens isolated at 190 medical centers in the USA. SPAR Study Group.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Bacteria; Drug Resistance, Microbial; Enterobacteriaceae; Fluoroquinolones; Haemophilus; Humans; In Vitro Techniques; Klebsiella; Moraxella catarrhalis; Oxacillin; Quinolones; Respiratory Tract Infections; Staphylococcus aureus; Streptococcus; Streptococcus pneumoniae; United States | 1997 |